Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 2
1983 3
1985 4
1986 3
1987 3
1988 2
1989 1
1990 4
1991 2
1992 2
1993 2
1994 1
1995 3
1996 2
1997 5
1998 7
1999 6
2000 11
2001 7
2002 5
2003 8
2004 5
2005 8
2006 7
2007 12
2008 13
2009 12
2010 8
2011 10
2012 23
2013 20
2014 17
2015 21
2016 25
2017 17
2018 23
2019 20
2020 15
2021 15
2022 12
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Primary Peritoneal Adenocarcinoma"
Page 1
Pseudomyxoma peritonei.
Hinson FL, Ambrose NS. Hinson FL, et al. Br J Surg. 1998 Oct;85(10):1332-9. doi: 10.1046/j.1365-2168.1998.00882.x. Br J Surg. 1998. PMID: 9782010 Review.
RESULTS AND CONCLUSIONS: There is increasing evidence that pseudomyxoma peritonei is a neoplastic condition which usually arises from a primary adenoma or adenocarcinoma of the appendix. Reported series include a spectrum of pathological lesions, from entirely benig …
RESULTS AND CONCLUSIONS: There is increasing evidence that pseudomyxoma peritonei is a neoplastic condition which usually arises from a p …
Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas.
Arias-Diaz AE, Ferreiro-Pantin M, Barbazan J, Perez-Beliz E, Ruiz-Bañobre J, Casas-Arozamena C, Muinelo-Romay L, Lopez-Lopez R, Vilar A, Curiel T, Abal M. Arias-Diaz AE, et al. Int J Mol Sci. 2023 Aug 25;24(17):13208. doi: 10.3390/ijms241713208. Int J Mol Sci. 2023. PMID: 37686015 Free PMC article.
Gynaecological serous carcinomas (GSCs) constitute a distinctive entity among female tumours characterised by a very poor prognosis. In addition to late-stage diagnosis and a high rate of recurrent disease associated with massive peritoneal carcinomatosis, th …
Gynaecological serous carcinomas (GSCs) constitute a distinctive entity among female tumours characterised by a very poor prognosis. …
Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and Colorectal Cancer: Outcomes and Survival.
Djadou TM, Poh KS, Yellinek S, Fayazzadeh H, El-Hayek K, Simpfendorfer CH, DaSilva G, Wexner SD. Djadou TM, et al. Am Surg. 2023 Dec;89(12):5757-5767. doi: 10.1177/00031348231175452. Epub 2023 May 8. Am Surg. 2023. PMID: 37155318
Univariate analysis of preoperative chemotherapy, primary malignancy location, primary tumor perforated or obstructive, postoperative bleeding complication, and pathology of adenocarcinoma, mucinous adenocarcinoma and negative lymph nodes were identifi …
Univariate analysis of preoperative chemotherapy, primary malignancy location, primary tumor perforated or obstructive, postop …
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F. Lutz MP, et al. Eur J Cancer. 2019 May;112:1-8. doi: 10.1016/j.ejca.2019.01.106. Epub 2019 Mar 15. Eur J Cancer. 2019. PMID: 30878666 Review.
Multimodal primary treatment of localised adenocarcinoma of the stomach, the oesophagus and the oesophagogastric junction (AEG) was reviewed by a multidisciplinary expert panel in a moderated consensus session. ...Expert treatment recommendations depend on the tumou …
Multimodal primary treatment of localised adenocarcinoma of the stomach, the oesophagus and the oesophagogastric junction (AEG …
The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?
Laban M, El-Swaify ST, Ali SH, Refaat MA, Sabbour M, Farrag N, Hassanin AS. Laban M, et al. Reprod Sci. 2022 Apr;29(4):1068-1085. doi: 10.1007/s43032-021-00565-8. Epub 2021 Apr 15. Reprod Sci. 2022. PMID: 33856667 Review.
Five to 10% of patients with stage IA, grade 1 or 2, endometrioid adenocarcinoma subsequently develop locoregional or distant recurrence. ...A systematic search of the literature on PubMed and Medline was conducted using the following search terms: endometrial cance …
Five to 10% of patients with stage IA, grade 1 or 2, endometrioid adenocarcinoma subsequently develop locoregional or distant recu …
Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA. Soslow RA, et al. Am J Surg Pathol. 2012 Dec;36(12):1771-81. doi: 10.1097/PAS.0b013e318273591a. Am J Surg Pathol. 2012. PMID: 23154767
It is unknown whether the type and grade of a primary endometrial carcinoma is reliably maintained in recurrence. All matched primary and recurrent endometrial carcinomas diagnosed from 2000 to 2010 at our institution were identified; 34 cases had avai …
It is unknown whether the type and grade of a primary endometrial carcinoma is reliably maintained in recurrence. All matched …
New therapeutic opportunities for women with low-grade serous ovarian cancer.
Moujaber T, Balleine RL, Gao B, Madsen I, Harnett PR, DeFazio A. Moujaber T, et al. Endocr Relat Cancer. 2021 Nov 11;29(1):R1-R16. doi: 10.1530/ERC-21-0191. Endocr Relat Cancer. 2021. PMID: 34636747 Review.
Women typically present at a younger age and have a protracted clinical course compared with the more common, high-grade serous ovarian cancer. ...Primary surgical cytoreduction to no visible residual disease remains a key prognostic factor; however, the use …
Women typically present at a younger age and have a protracted clinical course compared with the more common, high-grade serous ovari …
Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation.
Levy AD, Shaw JC, Sobin LH. Levy AD, et al. Radiographics. 2009 Mar-Apr;29(2):347-73. doi: 10.1148/rg.292085189. Radiographics. 2009. PMID: 19325052 Review.
When it arises from carcinomas of the gastrointestinal tract or ovary, the prognosis is grave. However, when low-grade mucinous adenocarcinoma of the appendix spreads to the peritoneal cavity, the consequence is typically pseudomyxoma peritonei, which is a cl …
When it arises from carcinomas of the gastrointestinal tract or ovary, the prognosis is grave. However, when low-grade mucinous ad …
Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma.
Oshita KO, Kobayashi T, Tadokoro T, Namba Y, Fukuhara S, Matsubara K, Takei D, Honmyo N, Kuroda S, Kawaoka T, Aikata H, Ohdan H. Oshita KO, et al. Anticancer Res. 2023 Nov;43(11):5189-5196. doi: 10.21873/anticanres.16720. Anticancer Res. 2023. PMID: 37909959
The median OS was 44.6 months (range=5.1-150.6 months), and the median survival after primary HCC diagnosis was 116.5 months (range=7.1-253.6 months). The median cumulative incidence of recurrent HCC was 7.2 months (range=0.3-94.7 months). ...A high alpha-fetoprotei …
The median OS was 44.6 months (range=5.1-150.6 months), and the median survival after primary HCC diagnosis was 116.5 months (range=7 …
Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naive patients: A single-center study.
Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Nikas IP, et al. Cancer Med. 2022 Jun;11(11):2193-2203. doi: 10.1002/cam4.4600. Epub 2022 Feb 25. Cancer Med. 2022. PMID: 35212471 Free PMC article.
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC), the most common histologic subtype of ovarian epithelial cancer, is associated with treatment resistance, enhanced recurrence rates, and poor prognosis. HGSOCs often metastasize to the peritoneal cavity …
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC), the most common histologic subtype of ovarian epithelial cancer, is associated with …
334 results